Ticker · CUSIP 03836J201

APRE

APREA THERAPEUTICS INC
···Share
Holders (tracked)
1
Combined shares
51,041
Combined value
$43.5K
Last close
—
Quarter
2025Q4
Tracked holders · last 8 quarters
Flat over the last 8 quarters.
112023Q12025Q4

SEC event timeline

1 events
  1. Ken Griffin (Citadel Advisors) opened position2026-02-17
    +51,041 shares · 2025Q4
    13F

Insider activity

No insider transactions in the last 30 days.
View full insider history for APRE →

Who moved on this name in 2025Q4

13F transactions reported for the latest quarter, grouped by direction.
New positions1
Added to0
—
Trimmed0
—
Exited0
—

Institutional ownership over time

Distinct super-investors holding this ticker · combined dollar value, by quarter.
QuarterHoldersCombined value
2023Q1
1
$41K
2023Q2
1
$29K
2023Q3
1
$38K
2023Q4
1
$40K
2024Q1
1
$57K
2024Q2
1
$35K
2025Q1
1
$61K
2025Q4
1
$44K

Who owns APRE

1 super-investors · 2025Q4
Tracked stake
51.0K
shares
Combined value
$44K
% of shares outstanding
—
shares-out unknown
Quarter action mix
New1
#ManagerSharesValue
1Ken Griffin
Citadel Advisors
51.0K$44K

Recent moves

4 transactions
Embed this chart
Paste this iframe anywhere to embed the live APRE chart.
<iframe src="https://openstocks.me/embed/stock/APRE" width="100%" height="480" frameborder="0" loading="lazy" title="APRE chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>
Preview: https://openstocks.me/embed/stock/APRE